152 related articles for article (PubMed ID: 16835862)
1. Phenotypic consequences of branch point substitutions.
Královicová J; Lei H; Vorechovský I
Hum Mutat; 2006 Aug; 27(8):803-13. PubMed ID: 16835862
[TBL] [Abstract][Full Text] [Related]
2. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
3. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.
Thi Tran HT; Takeshima Y; Surono A; Yagi M; Wada H; Matsuo M
Mol Genet Metab; 2005 Jul; 85(3):213-9. PubMed ID: 15979033
[TBL] [Abstract][Full Text] [Related]
4. Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition.
Královicová J; Vorechovsky I
Nucleic Acids Res; 2007; 35(19):6399-413. PubMed ID: 17881373
[TBL] [Abstract][Full Text] [Related]
5. Reported in vivo splice-site mutations in the factor IX gene: severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations.
Ketterling RP; Drost JB; Scaringe WA; Liao DZ; Liu JZ; Kasper CK; Sommer SS
Hum Mutat; 1999; 13(3):221-31. PubMed ID: 10090477
[TBL] [Abstract][Full Text] [Related]
6. Branch site haplotypes that control alternative splicing.
Královicová J; Houngninou-Molango S; Krämer A; Vorechovsky I
Hum Mol Genet; 2004 Dec; 13(24):3189-202. PubMed ID: 15496424
[TBL] [Abstract][Full Text] [Related]
7. Pre-mRNA splicing: a complex picture in higher definition.
Schellenberg MJ; Ritchie DB; MacMillan AM
Trends Biochem Sci; 2008 Jun; 33(6):243-6. PubMed ID: 18472266
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing and bioinformatic analysis of human U12-type introns.
Chang WC; Chen YC; Lee KM; Tarn WY
Nucleic Acids Res; 2007; 35(6):1833-41. PubMed ID: 17332017
[TBL] [Abstract][Full Text] [Related]
9. Disease-causing mutations improving the branch site and polypyrimidine tract: pseudoexon activation of LINE-2 and antisense Alu lacking the poly(T)-tail.
Meili D; Kralovicova J; Zagalak J; Bonafé L; Fiori L; Blau N; Thöny B; Vorechovsky I
Hum Mutat; 2009 May; 30(5):823-31. PubMed ID: 19280650
[TBL] [Abstract][Full Text] [Related]
10. An LKB1 AT-AC intron mutation causes Peutz-Jeghers syndrome via splicing at noncanonical cryptic splice sites.
Hastings ML; Resta N; Traum D; Stella A; Guanti G; Krainer AR
Nat Struct Mol Biol; 2005 Jan; 12(1):54-9. PubMed ID: 15608654
[TBL] [Abstract][Full Text] [Related]
11. The intron 1 of HPV 16 has a suboptimal branch point at a guanosine.
De la Rosa-Rios MA; Martínez-Salazar M; Martínez-Garcia M; González-Bonilla C; Villegas-Sepúlveda N
Virus Res; 2006 Jun; 118(1-2):46-54. PubMed ID: 16343675
[TBL] [Abstract][Full Text] [Related]
12. Biased exon/intron distribution of cryptic and de novo 3' splice sites.
Královicová J; Christensen MB; Vorechovský I
Nucleic Acids Res; 2005; 33(15):4882-98. PubMed ID: 16141195
[TBL] [Abstract][Full Text] [Related]
13. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
14. A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease.
Di Leo E; Panico F; Tarugi P; Battisti C; Federico A; Calandra S
Hum Mutat; 2004 Nov; 24(5):440. PubMed ID: 15459971
[TBL] [Abstract][Full Text] [Related]
15. Patterns of missplicing caused by RB1 gene mutations in patients with retinoblastoma and association with phenotypic expression.
Zhang K; Nowak I; Rushlow D; Gallie BL; Lohmann DR
Hum Mutat; 2008 Apr; 29(4):475-84. PubMed ID: 18181215
[TBL] [Abstract][Full Text] [Related]
16. Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing.
Krawczak M; Thomas NS; Hundrieser B; Mort M; Wittig M; Hampe J; Cooper DN
Hum Mutat; 2007 Feb; 28(2):150-8. PubMed ID: 17001642
[TBL] [Abstract][Full Text] [Related]
17. Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants.
Mukhopadhyay A; Nikopoulos K; Maugeri A; de Brouwer AP; van Nouhuys CE; Boon CJ; Perveen R; Zegers HA; Wittebol-Post D; van den Biesen PR; van der Velde-Visser SD; Brunner HG; Black GC; Hoyng CB; Cremers FP
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3565-72. PubMed ID: 16877430
[TBL] [Abstract][Full Text] [Related]
18. The effect of disease-associated HRPT2 mutations on splicing.
Hahn MA; McDonnell J; Marsh DJ
J Endocrinol; 2009 Jun; 201(3):387-96. PubMed ID: 19332451
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into group II intron catalysis and branch-site selection.
Zhang L; Doudna JA
Science; 2002 Mar; 295(5562):2084-8. PubMed ID: 11859154
[TBL] [Abstract][Full Text] [Related]
20. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
